Affymetrix licenses Caliper technology

April 25, 2005 — Caliper Life Sciences Inc. of Hopkinton, Mass., and Affymetrix Inc. of Santa Clara, Calif., announced that Caliper has issued Affymetrix a non-exclusive license to use a portion of Caliper’s microfluidics patent estate with Affymetrix’s GeneChip microarray technologies.

The license extends to the manufacture and sale of GeneChip brand products in all areas of application, including research, diagnostics and applied genomics applications, according to a news release issued by both companies. In exchange for the license, Affymetrix will pay upfront licensing fees and royalties on future products covered under the agreement. Further financial details related to the agreement were not disclosed.

The agreement is the second agreement since Caliper began an active program to license its intellectual property portfolio. The new program was put in place to support the company’s microfluidics adoption strategy and to broaden and accelerate the availability of new technologies and products for life science and diagnostics applications.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.